‘We are excited to have produced such great progress inside our research and look forward to receiving SFDA acceptance for the creation of both of our eyes products within 2 yrs,’ commented Mr. Yan-qing Liu, CEO and Chairman of China Sky 1 Medical. ‘We are fully committed to increasing our medication portfolio by getting quality new products into the Chinese market.’.. China Sky One Medical submits software to execute clinical trials for two new generic drugs China Sky A single Medical, Inc. , a respected fully integrated pharmaceutical business producing over-the-counter medications in the People’s Republic of China , today announced that the Company has finished the mandatory research for just two new generic medications for eyes treatment and submitted software to the State Meals and Drug Administration in China to perform scientific trials.The app features a sophisticated weight tracker, dining out calorie counter, and calculates calories from fat burned by exercise. According to the American University of Obstetricians and Gynecologists 1 / 3 of adult females in the usa are obese. During pregnancy, obese women are in elevated risk for maternal and fetal complications and unwanted weight gain during pregnancy substantially contributes to postpartum excess weight retention and the obesity epidemic. Experts are recruiting women at their post-partum visits and following them for three months.
Bayer’s Ciprofloxacin DPI receives FDA orphan medication designation for NCFB treatment Today announced that the U Bayer HealthCare.S. Food and Medication Administration's Workplace of Orphan Products Advancement has granted orphan medication designation because of its investigational Ciprofloxacin Dry out Powder for Inhalation for the treating non-cystic fibrosis bronchiectasis .